Type 1 diabetes can be a grizzly beast of a disease for children suffering with it from a physical standpoint. Let alone the social anxiety that comes along for the ride. No child wants to stop playing with their friends to have to test their blood. Equally embarassing can be the need to be excused [...]

Thank you to Zoe Dunn, Principal, HALE ADVISORS INC for this blog post.  The Pharmaceutical industry may just have the social media guardrails it has long been waiting for. While the Food & Drug Administration (FDA), which regulates the industry, hasn’t yet issued its promised social media guidance, it may just defer to the newly-released Federal [...]

It has been frustrating to attend so many of our Digital Pharma events over the past few years and notice the huge disparity in the tightness of digital handcuffs that have been placed on our speakers and attendees by their organizations. As an organizer of events, we want so badly for our conferences to be [...]

Thanks to widespread use of mobile technology, health care providers can access patient information on the go. While increasing use of mobile devices in healthcare can lead to greater efficiency, it also has the potential to create security headaches for providers who must remain compliant with HIPAA regulations. Utilizing mobile devices for storing health information [...]

There is inescapable logic in gamifying medication adherence among children. Kids often rely on parents to take medications and to complete courses of treatment. Unfortunately, adults don’t take their own medications with a very high level of success. An estimated 75 percent of adults are not successful in the area of patient adherence. Children relying [...]

What amazing feedback we’re getting out of the 5th Digital Pharma Europe that took place February 25-27 at the Bristol-Myers Squibb headquarters in Paris, France. We had over 150 participants from 59 companies and 15 countries.  If you couldn’t attend, here’s what you missed: The Multi-Channel Debate: The knowledge shared by the participants including Bayer, BMS, Merck, [...]

The consequences of poor planning and procrastination in the approval process have plagued the progress of new initiatives in the pharmaceutical industry for years. While gaining approval from Med/Legal/Regulatory (MLR) teams is meant to ensure stable, ethical, and lucrative production, the deployment of these new initiatives often fall behind and cost the company time and [...]

Special thanks to Nancy Meyer at Hale Advisors, Inc. for sharing this blog entry.  The healthcare sector spends millions of dollars on advertising, but how much of what is being communicated is really being understood? When one considers that as many as half of all American adults have limited literacy skills and even more—as many as [...]

Special thanks to Michael Spitz (@SpitzStrategy) at Pixel and Pills for sharing his experiences onsite at the 6th Digital Pharma East.  On behalf of the entire Pixels and Pills blog crew, we were thrilled to attend and honored to help capture some of the wonderful thinking and compelling innovation surrounding the 6th Annual Digital Pharma [...]